{"id":5515,"date":"2016-09-12T16:18:47","date_gmt":"2016-09-12T20:18:47","guid":{"rendered":"http:\/\/www.thet3trader.com\/?p=5515"},"modified":"2016-09-12T16:18:47","modified_gmt":"2016-09-12T20:18:47","slug":"t3s-take-3-biotech-fed-chatter-rescues-crying-bulls","status":"publish","type":"post","link":"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/","title":{"rendered":"T3’s Take 3: Biotech, Fed Chatter Rescues Crying Bulls"},"content":{"rendered":"

1)\u00a0Bulls Fight Back<\/strong><\/p>\n

The S&P 500<\/strong> fell -0.4% to 2119.12 in the early going, which had traders worrying that we'd see a repeat of Friday's horrendous action.<\/p>\n

We also saw early weakness in overseas equities, crude oil, bonds, and gold.<\/p>\n

However, traders very quickly bought the dip, and the S&P finished up 1.5% at 2159.04.<\/p>\n

This was the first 1% up day in the S&P 500 since July 8.<\/p>\n

And since Friday was the first -1% down day since June 27, perhaps we are seeing a real return to volatility after 2 months of near-zero movement.<\/p>\n

2) Biotech Saves the Day<\/strong><\/p>\n

The first clue that the bull was ready to fight back was the early rebound in biotech<\/strong> (IBB), which was supported by 3 pieces of favorable news.<\/p>\n

First,\u00a0Horizon Pharma<\/strong> (HZNP) announced it is buying Raptor Pharmaceutical<\/strong> (RPTP)\u00a0for $800 million.<\/p>\n

Gilead<\/strong> (GILD) CEO John Milligan also said at an investment conference that the company planned on making regular acquisitions.<\/p>\n

And finally, Presidential candidate Hillary Clinton fell ill at a 9\/11 Memorial Service in New York.<\/p>\n

Since she is viewed as anti-biotech, anything that hurts her chances of becoming President helps the sector.<\/p>\n

The Nasdaq Biotech Index<\/strong> (IBB) rose 3.0% to $287.11 today.<\/p>\n

3)\u00a0Fed Schmed<\/strong><\/p>\n

This afternoon, Lael Brainard, a voting member of the Federal Open Market Market Committee, gave a highly-anticipated speech in Chicago.<\/p>\n

Brainard's speech leaned dovish, making a case for leaving rates as-is.<\/p>\n

Considering that Brainard is considered to be one of more dovish members of the Fed, this was not a major surprise.<\/p>\n

However, her speech had a big impact on markets: the US dollar fell, while gold and stocks ripped higher.<\/p>\n

Traders are also now pricing in a mere 22% of a September rate hike, down from 32% a week ago.<\/p>\n

Throughout August, traders loved hawkish Fed chatter.<\/p>\n

It looks like that's flipped around now.<\/p>\n

Tuesday's Trading Calendar<\/strong><\/span><\/p>\n

US Economics (Time Zone: EDT)<\/strong><\/p>\n

06:00 NFIB Small Business Optimism (Aug): exp. 94.8 , prior 94.6
\n14:00 Monthly Budget Statement (Aug): exp. -$107.0b , prior -$64.4b<\/p>\n

Global Economics<\/strong><\/p>\n

03:15 CHF PPI m\/m
\n04:30 GBP CPI y\/y
\n05:00 EUR ECB Pres. Draghi Speaks
\n05:00 EUR German ZEW Economic Sentiment
\n18:45 NZD Current Account<\/p>\n

Earnings<\/strong><\/p>\n

Before Open:<\/p>\n

None of Significance<\/strong><\/p>\n

After Close:<\/p>\n

None of Significance<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

1)\u00a0Bulls Fight Back The S&P 500 fell -0.4% to 2119.12 in the early going, which had traders worrying that we’d see a repeat of Friday’s horrendous action. We also saw early weakness in overseas equities, crude oil, bonds, and gold. However, traders very quickly bought the dip, and the S&P finished up 1.5% at 2159.04. This was the first 1% up day in the S&P 500 since July 8. And since Friday was the first -1% down day since June 27, perhaps we are seeing a real return to volatility after 2 months of near-zero movement. 2) Biotech Saves the Day The first clue that the bull was ready to fight back was the early rebound in biotech (IBB), which was supported by 3 pieces of favorable news. First,\u00a0Horizon Pharma (HZNP) announced it is buying Raptor Pharmaceutical (RPTP)\u00a0for $800 million. Gilead (GILD) CEO John Milligan also said at an investment conference that the company planned on making regular acquisitions. And finally, Presidential candidate Hillary Clinton fell ill at a 9\/11 Memorial Service in New York. Since she is viewed as anti-biotech, anything that hurts her chances of becoming President helps the sector. The Nasdaq Biotech Index (IBB) rose 3.0% to $287.11 today. 3)\u00a0Fed Schmed This afternoon, Lael Brainard, a voting member of the Federal Open Market Market Committee, gave a highly-anticipated speech in Chicago. Brainard’s speech leaned dovish, making a case for leaving rates as-is. Considering that Brainard is considered to be one of more dovish members of the Fed, this was not a major surprise. However, her speech had a big impact on markets: the US dollar fell, while gold and stocks ripped higher. Traders are also now pricing in a mere 22% of a September rate hike, down from 32% a week ago. Throughout August, traders loved hawkish Fed chatter. It looks like that’s flipped around now. Tuesday’s Trading Calendar US Economics (Time Zone: EDT) 06:00 NFIB Small Business Optimism (Aug): exp. 94.8 , prior 94.6 14:00 Monthly Budget Statement (Aug): exp. -$107.0b , prior -$64.4b Global Economics 03:15 CHF PPI m\/m 04:30 GBP CPI y\/y 05:00 EUR ECB Pres. Draghi Speaks 05:00 EUR German ZEW Economic Sentiment 18:45 NZD Current Account Earnings Before Open: None of Significance After Close: None of Significance<\/p>\n","protected":false},"author":6,"featured_media":4096,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2,1],"tags":[266,36,189,147,92,107],"class_list":["post-5515","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","category-uncategorized","tag-brainard","tag-daily-recap","tag-daily-recap-article","tag-economics","tag-fed","tag-take-3"],"yoast_head":"\nT3's Take 3: Biotech, Fed Chatter Rescues Crying Bulls - T3 Live<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"T3's Take 3: Biotech, Fed Chatter Rescues Crying Bulls - T3 Live\" \/>\n<meta property=\"og:description\" content=\"1)\u00a0Bulls Fight Back The S&P 500 fell -0.4% to 2119.12 in the early going, which had traders worrying that we'd see a repeat of Friday's horrendous action. We also saw early weakness in overseas equities, crude oil, bonds, and gold. However, traders very quickly bought the dip, and the S&P finished up 1.5% at 2159.04. This was the first 1% up day in the S&P 500 since July 8. And since Friday was the first -1% down day since June 27, perhaps we are seeing a real return to volatility after 2 months of near-zero movement. 2) Biotech Saves the Day The first clue that the bull was ready to fight back was the early rebound in biotech (IBB), which was supported by 3 pieces of favorable news. First,\u00a0Horizon Pharma (HZNP) announced it is buying Raptor Pharmaceutical (RPTP)\u00a0for $800 million. Gilead (GILD) CEO John Milligan also said at an investment conference that the company planned on making regular acquisitions. And finally, Presidential candidate Hillary Clinton fell ill at a 9\/11 Memorial Service in New York. Since she is viewed as anti-biotech, anything that hurts her chances of becoming President helps the sector. The Nasdaq Biotech Index (IBB) rose 3.0% to $287.11 today. 3)\u00a0Fed Schmed This afternoon, Lael Brainard, a voting member of the Federal Open Market Market Committee, gave a highly-anticipated speech in Chicago. Brainard's speech leaned dovish, making a case for leaving rates as-is. Considering that Brainard is considered to be one of more dovish members of the Fed, this was not a major surprise. However, her speech had a big impact on markets: the US dollar fell, while gold and stocks ripped higher. Traders are also now pricing in a mere 22% of a September rate hike, down from 32% a week ago. Throughout August, traders loved hawkish Fed chatter. It looks like that's flipped around now. Tuesday's Trading Calendar US Economics (Time Zone: EDT) 06:00 NFIB Small Business Optimism (Aug): exp. 94.8 , prior 94.6 14:00 Monthly Budget Statement (Aug): exp. -$107.0b , prior -$64.4b Global Economics 03:15 CHF PPI m\/m 04:30 GBP CPI y\/y 05:00 EUR ECB Pres. Draghi Speaks 05:00 EUR German ZEW Economic Sentiment 18:45 NZD Current Account Earnings Before Open: None of Significance After Close: None of Significance\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/\" \/>\n<meta property=\"og:site_name\" content=\"T3 Live\" \/>\n<meta property=\"article:published_time\" content=\"2016-09-12T20:18:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blog.t3live.com\/wp-content\/uploads\/2016\/07\/market-analyze-01.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"548\" \/>\n\t<meta property=\"og:image:height\" content=\"365\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Michael Comeau\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Michael Comeau\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/\"},\"author\":{\"name\":\"Michael Comeau\",\"@id\":\"https:\/\/blog.t3live.com\/#\/schema\/person\/f43d6289d690d77d2d21b55beeb1508b\"},\"headline\":\"T3’s Take 3: Biotech, Fed Chatter Rescues Crying Bulls\",\"datePublished\":\"2016-09-12T20:18:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/\"},\"wordCount\":373,\"publisher\":{\"@id\":\"https:\/\/blog.t3live.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/blog.t3live.com\/wp-content\/uploads\/2016\/07\/market-analyze-01.jpg\",\"keywords\":[\"brainard\",\"daily recap\",\"daily recap article\",\"economics\",\"fed\",\"Take 3\"],\"articleSection\":[\"Articles\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/\",\"url\":\"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/\",\"name\":\"T3's Take 3: Biotech, Fed Chatter Rescues Crying Bulls - T3 Live\",\"isPartOf\":{\"@id\":\"https:\/\/blog.t3live.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/blog.t3live.com\/wp-content\/uploads\/2016\/07\/market-analyze-01.jpg\",\"datePublished\":\"2016-09-12T20:18:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/#primaryimage\",\"url\":\"https:\/\/blog.t3live.com\/wp-content\/uploads\/2016\/07\/market-analyze-01.jpg\",\"contentUrl\":\"https:\/\/blog.t3live.com\/wp-content\/uploads\/2016\/07\/market-analyze-01.jpg\",\"width\":548,\"height\":365},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/blog.t3live.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"T3’s Take 3: Biotech, Fed Chatter Rescues Crying Bulls\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/blog.t3live.com\/#website\",\"url\":\"https:\/\/blog.t3live.com\/\",\"name\":\"T3 Live\",\"description\":\"Real Traders, Real Time\",\"publisher\":{\"@id\":\"https:\/\/blog.t3live.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/blog.t3live.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/blog.t3live.com\/#organization\",\"name\":\"T3 Live\",\"url\":\"https:\/\/blog.t3live.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/blog.t3live.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/blog.t3live.com\/wp-content\/uploads\/2026\/09\/T3-Live-Logo-white.png\",\"contentUrl\":\"https:\/\/blog.t3live.com\/wp-content\/uploads\/2026\/09\/T3-Live-Logo-white.png\",\"width\":658,\"height\":292,\"caption\":\"T3 Live\"},\"image\":{\"@id\":\"https:\/\/blog.t3live.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/blog.t3live.com\/#\/schema\/person\/f43d6289d690d77d2d21b55beeb1508b\",\"name\":\"Michael Comeau\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/blog.t3live.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/db58f7ea44ada1d8554c78087941a1a187ef3a61c7521fc8751fc7ab4424a3ce?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/db58f7ea44ada1d8554c78087941a1a187ef3a61c7521fc8751fc7ab4424a3ce?s=96&d=mm&r=g\",\"caption\":\"Michael Comeau\"},\"url\":\"https:\/\/blog.t3live.com\/author\/michael-comeau\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"T3's Take 3: Biotech, Fed Chatter Rescues Crying Bulls - T3 Live","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/","og_locale":"en_US","og_type":"article","og_title":"T3's Take 3: Biotech, Fed Chatter Rescues Crying Bulls - T3 Live","og_description":"1)\u00a0Bulls Fight Back The S&P 500 fell -0.4% to 2119.12 in the early going, which had traders worrying that we'd see a repeat of Friday's horrendous action. We also saw early weakness in overseas equities, crude oil, bonds, and gold. However, traders very quickly bought the dip, and the S&P finished up 1.5% at 2159.04. This was the first 1% up day in the S&P 500 since July 8. And since Friday was the first -1% down day since June 27, perhaps we are seeing a real return to volatility after 2 months of near-zero movement. 2) Biotech Saves the Day The first clue that the bull was ready to fight back was the early rebound in biotech (IBB), which was supported by 3 pieces of favorable news. First,\u00a0Horizon Pharma (HZNP) announced it is buying Raptor Pharmaceutical (RPTP)\u00a0for $800 million. Gilead (GILD) CEO John Milligan also said at an investment conference that the company planned on making regular acquisitions. And finally, Presidential candidate Hillary Clinton fell ill at a 9\/11 Memorial Service in New York. Since she is viewed as anti-biotech, anything that hurts her chances of becoming President helps the sector. The Nasdaq Biotech Index (IBB) rose 3.0% to $287.11 today. 3)\u00a0Fed Schmed This afternoon, Lael Brainard, a voting member of the Federal Open Market Market Committee, gave a highly-anticipated speech in Chicago. Brainard's speech leaned dovish, making a case for leaving rates as-is. Considering that Brainard is considered to be one of more dovish members of the Fed, this was not a major surprise. However, her speech had a big impact on markets: the US dollar fell, while gold and stocks ripped higher. Traders are also now pricing in a mere 22% of a September rate hike, down from 32% a week ago. Throughout August, traders loved hawkish Fed chatter. It looks like that's flipped around now. Tuesday's Trading Calendar US Economics (Time Zone: EDT) 06:00 NFIB Small Business Optimism (Aug): exp. 94.8 , prior 94.6 14:00 Monthly Budget Statement (Aug): exp. -$107.0b , prior -$64.4b Global Economics 03:15 CHF PPI m\/m 04:30 GBP CPI y\/y 05:00 EUR ECB Pres. Draghi Speaks 05:00 EUR German ZEW Economic Sentiment 18:45 NZD Current Account Earnings Before Open: None of Significance After Close: None of Significance","og_url":"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/","og_site_name":"T3 Live","article_published_time":"2016-09-12T20:18:47+00:00","og_image":[{"width":548,"height":365,"url":"https:\/\/blog.t3live.com\/wp-content\/uploads\/2016\/07\/market-analyze-01.jpg","type":"image\/jpeg"}],"author":"Michael Comeau","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Michael Comeau","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/#article","isPartOf":{"@id":"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/"},"author":{"name":"Michael Comeau","@id":"https:\/\/blog.t3live.com\/#\/schema\/person\/f43d6289d690d77d2d21b55beeb1508b"},"headline":"T3’s Take 3: Biotech, Fed Chatter Rescues Crying Bulls","datePublished":"2016-09-12T20:18:47+00:00","mainEntityOfPage":{"@id":"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/"},"wordCount":373,"publisher":{"@id":"https:\/\/blog.t3live.com\/#organization"},"image":{"@id":"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/#primaryimage"},"thumbnailUrl":"https:\/\/blog.t3live.com\/wp-content\/uploads\/2016\/07\/market-analyze-01.jpg","keywords":["brainard","daily recap","daily recap article","economics","fed","Take 3"],"articleSection":["Articles"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/","url":"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/","name":"T3's Take 3: Biotech, Fed Chatter Rescues Crying Bulls - T3 Live","isPartOf":{"@id":"https:\/\/blog.t3live.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/#primaryimage"},"image":{"@id":"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/#primaryimage"},"thumbnailUrl":"https:\/\/blog.t3live.com\/wp-content\/uploads\/2016\/07\/market-analyze-01.jpg","datePublished":"2016-09-12T20:18:47+00:00","breadcrumb":{"@id":"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/#primaryimage","url":"https:\/\/blog.t3live.com\/wp-content\/uploads\/2016\/07\/market-analyze-01.jpg","contentUrl":"https:\/\/blog.t3live.com\/wp-content\/uploads\/2016\/07\/market-analyze-01.jpg","width":548,"height":365},{"@type":"BreadcrumbList","@id":"https:\/\/blog.t3live.com\/2016\/09\/12\/t3s-take-3-biotech-fed-chatter-rescues-crying-bulls\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blog.t3live.com\/"},{"@type":"ListItem","position":2,"name":"T3’s Take 3: Biotech, Fed Chatter Rescues Crying Bulls"}]},{"@type":"WebSite","@id":"https:\/\/blog.t3live.com\/#website","url":"https:\/\/blog.t3live.com\/","name":"T3 Live","description":"Real Traders, Real Time","publisher":{"@id":"https:\/\/blog.t3live.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blog.t3live.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blog.t3live.com\/#organization","name":"T3 Live","url":"https:\/\/blog.t3live.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blog.t3live.com\/#\/schema\/logo\/image\/","url":"https:\/\/blog.t3live.com\/wp-content\/uploads\/2026\/09\/T3-Live-Logo-white.png","contentUrl":"https:\/\/blog.t3live.com\/wp-content\/uploads\/2026\/09\/T3-Live-Logo-white.png","width":658,"height":292,"caption":"T3 Live"},"image":{"@id":"https:\/\/blog.t3live.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blog.t3live.com\/#\/schema\/person\/f43d6289d690d77d2d21b55beeb1508b","name":"Michael Comeau","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blog.t3live.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/db58f7ea44ada1d8554c78087941a1a187ef3a61c7521fc8751fc7ab4424a3ce?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/db58f7ea44ada1d8554c78087941a1a187ef3a61c7521fc8751fc7ab4424a3ce?s=96&d=mm&r=g","caption":"Michael Comeau"},"url":"https:\/\/blog.t3live.com\/author\/michael-comeau\/"}]}},"_links":{"self":[{"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/posts\/5515","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/comments?post=5515"}],"version-history":[{"count":0,"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/posts\/5515\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/media\/4096"}],"wp:attachment":[{"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/media?parent=5515"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/categories?post=5515"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/tags?post=5515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}